“Abemaciclib in Real Clinical Practice of Adjuvant Therapy of HR+ HER2- High-Risk Breast Cancer: Experience of Centers in Moscow”. Voprosy Onkologii, vol. 71, no. 3, June 2025, p. OF-2319, https://doi.org/10.37469/0507-3758-2025-71-3-OF-2319.